Correspondence 0001193125-24-201272 from MiNK Therapeutics, Inc. (INKT) (CIK 0001840229) (INKT)
MiNK Therapeutics, Inc. (INKT) (CIK 0001840229)
Date: Aug. 15, 2024 · CIK: 0001840229 · Accession: 0001193125-24-201272
AI Filing Summary & Sentiment
Letter
MiNK Therapeutics, Inc.
149 Fifth Street, Suite 500
New York, NY 10010
August 15, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jimmy McNamara
Re: MiNK Therapeutics, Inc.
Registration Statement on Form S-3 (File No. 333- 281522)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, MiNK Therapeutics, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on August 16, 2024, or as soon as possible thereafter. The Company hereby authorizes Zachary Blume of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please contact Zachary Blume (zachary.blume@ropesgray.com) / telephone: (617) 951-7000 of Ropes & Gray LLP as soon as the registration statement has been declared effective.
[Signature page follows]
Very truly yours,
MINK THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP MiNK Therapeutics, Inc. 149 Fifth Street, Suite 500 New York, NY 10010 August 15, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jimmy McNamara Re: MiNK Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333- 281522) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, MiNK Therapeutics, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on August 16, 2024, or as soon as possible thereafter. The Company hereby authorizes Zachary Blume of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please contact Zachary Blume (zachary.blume@ropesgray.com) / telephone: (617) 951-7000 of Ropes & Gray LLP as soon as the registration statement has been declared effective. [Signature page follows] Very truly yours, MINK THERAPEUTICS, INC. By: /s/ Christine Klaskin Name: Christine Klaskin Title: Treasurer [Signature Page to Acceleration Request]